Angiosarcoma does not behave like many other cancers. Patients often say they wish they had understood early on that getting evaluated at a high-volume sarcoma clinic with expertise in angiosarcoma is crucial.
Because angiosarcoma is so rare, many patients and families find each other online. The most active peer-led space is the Angiosarcoma Cancer Facebook group.
Many patients seek care or second opinions at centers with dedicated sarcoma programs. We reference sarcoma centers identified by the Sarcoma Foundation of America (SFA) as a starting point.
Clinical trials are often where new sarcoma treatments are tested. Because angiosarcoma is rare, trials may be listed under sarcoma rather than angiosarcoma specifically.
Patients can search independently, but it is often more effective to ask their care team to actively look for relevant trials and discuss options together as part of treatment planning.
Some patients may benefit from financial assistance to obtain a second opinion at a sarcoma center. The Sarcoma Alliance offers Second Opinion Grants that may help cover travel and consultation costs.
